abrysvo
pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcije respiratornih sincicijskih virusov - cepiva - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. glej poglavja 4. 2 in 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcije respiratornih sincicijskih virusov - cepiva - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
kybernin p 500 i.e. prašek in vehikel za raztopino za injiciranje/infundiranje
csl behring gmbh - antitrombin - prašek in vehikel za raztopino za injiciranje/infundiranje - antitrombin 500 i.e. / 1 viala - antitrombin
nyvepria
pfizer europe ma eeig - pegfilgrastim - nevtropenija - immunostimulants, - skrajšanje trajanja nevtropenija in pojavnost vročinskih nevtropenija pri odraslih bolnikih, zdravljenih s citotoksično kemoterapijo za malignosti (razen kronično mieloično levkemijo in mielodisplastični sindrom).
beyfortus
astrazeneca ab - nirsevimab - imunski sera in imunoglobulini, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
vantobra (previously tobramycin pari)
pari pharma gmbh - tobramycin - respiratory tract infections; cystic fibrosis - antibacterials za sistemsko uporabo, - vantobra je označen za upravljanje kronično pljučno okužbo, zaradi pseudomonas aeruginosa pri bolnikih, starih 6 let in več, s cistično fibrozo (cf). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
ampril hd 5 mg/25 mg tablete
krka, d.d., novo mesto - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 25 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ampril hl 2,5 mg/12,5 mg tablete
krka, d.d., novo mesto - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta ramipril2,5 mg / 1 tableta; ramipril 2,5 mg / 1 tableta - ramipril in diuretiki
atacand plus 16 mg/12,5 mg tablete
astrazeneca ab - hidroklorotiazid; cileksetilkandesartanat - tableta - hidroklorotiazid 12,5 mg / 1 tableta cileksetilkandesartanat16 mg / 1 tableta; cileksetilkandesartanat 16 mg / 1 tableta - kandesartan in diuretiki
budelin novolizer 200 mikrogramov/odmerek prašek za inhaliranje, odmerjen
meda pharma gmbh & co. kg - budezonid - prašek za inhaliranje, odmerjeni - budezonid 200 µg / 1 odmerek - budezonid